<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="preparation" /><meta name="keywords" content="Soliris; Eculizumab" /><meta name="IX" content="Soliris; Eculizumab" /><title>Soliris®: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="265/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="35091.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="200191.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="200191.htm#pB" title="Skip Navigation">Skip Navigation</a><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=200191.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 26 May 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF No. 63 (March 2012)</a> &gt; <a href="2076.htm">9 Nutrition and blood</a> &gt; <a href="4843.htm">9.1 Anaemias and some other blood disorders</a> &gt; <a href="4910.htm">9.1.3 Drugs used in hypoplastic, haemolytic, and renal anaemias</a> &gt; <a href="200186.htm">Paroxysmal nocturnal haemoglobinuria </a> &gt; <a href="200187.htm">ECULIZUMAB</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="200186.htm" title="Previous: Paroxysmal nocturnal haemoglobinuria">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="4924.htm" title="Next: 9.1.4 Drugs used in platelet disorders">Next page</a> ►</div></div></div></div><div id="p1"><div id="sideBar"><h2>See Also</h2><ul><li><h3>AHFS Drug Information</h3></li><li><a href="http://www.medicinescomplete.com/mc/ahfs/2010/a307019.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Eculizumab</a><div class="breadcrumb"><p><strong>AHFS Drug Information</strong> &gt; Miscellaneous Therapeutic Agents 92:00 &gt; Complement Inhibitors 92:32</p></div></li></ul><ul><li><h3>British National Formulary (3)</h3></li><li><a href="200186.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Paroxysmal nocturnal haemoglobinuria </a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 9 Nutrition and blood &gt; 9.1 Anaemias and some other blood disorders &gt; 9.1.3 Drugs used in hypoplastic, haemolytic, and renal anaemias</p></div></li><li><a href="200187.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">ECULIZUMAB</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 9 Nutrition and blood &gt; 9.1 Anaemias and some other blood disorders &gt; 9.1.3 Drugs used in hypoplastic, haemolytic, and renal anaemias &gt; Paroxysmal nocturnal haemoglobinuria </p></div></li><li><a href="200275.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Eculizumab</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; Appendix 4 Intravenous additives &gt; Use of table &gt; Table of drugs given by intravenous infusion</p></div></li></ul><ul><li><h3>Martindale: The Complete Drug Reference (2)</h3></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/21182-q.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Eculizumab</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Miscellaneous Drugs and Other Substances &gt; Drug Monographs</p></div></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/5789-z.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Pexelizumab</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Miscellaneous Drugs and Other Substances &gt; Drug Monographs</p></div></li></ul><ul><li><h3>The Merck Index</h3></li><li><a href="http://www.medicinescomplete.com/mc/merck/2010/03506.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Eculizumab</a><div class="breadcrumb"><p><strong>The Merck Index</strong> &gt; Monographs &gt; E &gt; EC</p></div></li></ul><script type="text/javascript" src="scripts/sidebar.js"></script></div><div id="pB"><h1 id="_200187">ECULIZUMAB</h1><div id="pC" class="jN"><div class="cAF"><h2>Indications</h2> <p class="cAF">paroxysmal nocturnal haemoglobinuria,
in those with a history of blood transfusions (specialist use only)</p></div><div class="cAF"><h2>Cautions</h2> <p class="cAF">active systemic infection; monitor for intravascular haemolysis (including serum-lactate
dehydrogenase concentration) for at least 8 weeks after discontinuation</p><div class="cAV"><h3>Meningococcal infection</h3> <p class="cAX">Vaccinate
against <span class="cAC">Neisseria meningitidis</span> at least 2 weeks
before treatment (tetravalent vaccine against serotypes A, C, W135
and Y recommended); revaccinate according to current medical guidelines. Advise patient to report promptly any signs of meningococcal
infection. Other immunisations should also be up to date (<a title="section: Active immunity" href="6451.htm#_6451">section 14.1</a>)</p></div></div><div class="cAF"><h2>Contra-indications</h2> <p class="cAF">unresolved <span class="cAC">Neisseria
meningitidis</span> infection; patients
unvaccinated against <span class="cAC">Neisseria meningitidis</span> (see Cautions above); known or suspected hereditary complement
deficiencies</p></div><div class="cAF"><h2>Pregnancy</h2> <p class="cAF">no information available—use only if potential benefit
outweighs risk; human IgG antibodies known to cross placenta; manufacturer
advises effective contraception during and for 5 months after treatment</p></div><div class="cAF"><h2>Breast-feeding</h2> <p class="cAF">no information available—manufacturer advises
avoid breast-feeding during and for 5 months after treatment</p></div><div class="cAF"><h2>Side-effects</h2> <p class="cAF">gastro-intestinal disturbances; oedema; cough,
nasopharyngitis; headache, dizziness, fatigue, dysgeusia, paraesthesia;
infection (including meningococcal infection); spontaneous erection,
dysuria; arthralgia, myalgia; blood disorders (including thrombocytopenia);
alopecia, pruritus, rash; influenza-like symptoms; infusion-related
reactions; <i>less commonly</i> anorexia, gingival pain,
jaundice, palpitation, haematoma, hypotension, chest pain, syncope,
hot flushing, epistaxis, anxiety, depression, mood changes, sleep
disturbances, Graves’ disease, menstrual disorders, renal impairment,
malignant melanoma, muscle spasms, myelodysplastic syndrome, visual
disturbances, tinnitus, hyperhidrosis, petechiae, and skin depigmentation</p></div><div class="cAF"><h2>Dose</h2> <p class="cR"><span class="cU">By intravenous infusion</span>, <span class="cAK">adult</span> over 18 years, initially 600 mg once a week
for 4 weeks, then 900 mg on week 5; maintenance, 900 mg once every
12–16 days</p></div></div><?highlighter on?><div id="pS"><p>Sub-sections</p><ul class="jT"><li class="jN" id="_200191" style="margin: 0 0 0 20px;"><h1 class="title">Soliris®<span> (<a href="appendix-112803-A.htm#m745">Alexion</a>)</span> <img class="cJ" src="images/pom_l.png" title="Prescription-only Medicine" alt="Prescription-only Medicine" /></h1><div class="cAY"><span class="cAB">Concentrate for intravenous infusion</span>, eculizumab 10 mg/mL, net price 30-mL vial = £3150.00. Counselling,
meningococcal infection, patient information card<div class="cAP"><span class="cAH">Electrolytes: </span>Na<sup>+</sup> 5 mmol/vial</div></div></li></ul></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="200186.htm">Previous: Paroxysmal nocturnal haemoglobinuria </a> | <a class="top" href="200191.htm#">Top</a> | <a accesskey="]" href="4924.htm">Next: 9.1.4 Drugs used in platelet disorders</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Privacy Policy">Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="35091.htm" rel="copyright">Copyright © BMJ Group and the Royal Pharmaceutical Society of Great Britain 2012. All rights reserved.</a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>